Astera Labs, Inc. Liquidation Value

ALAB Other

Cash & Equivalents

$167.61M
As of 2025-12-31
Current Price: $197.54 (as of 2026-04-24)

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $167.61M
Total Obligations: -$164.02M
$3.60M
Per share: $0.02
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $167.61M
AR: $83.20M
Total Obligations: -$164.02M
$86.80M
Per share: $0.51
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $167.61M
AR: $83.20M
Inventory: $58.98M
Total Obligations: -$164.02M
$145.78M
Per share: $0.86
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$3.60M$0.02
Liquid Liquidation Value$86.80M$0.51
Operating Liquidation Value$145.78M$0.86

Key Components (as of 2025-12-31)

Cash & Equivalents$167.61M
Accounts Receivable$83.20M
Inventory$58.98M
Current Liabilities$133.04M
Long-term DebtN/A
Op. Lease Liability$30.97M
Finance LeaseN/A
Shares Outstanding170.2M

Explore all 188 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$167.61M$83.20M$58.98M$42.36M$133.04MN/A$30.97MN/A
2025-09-30$140.41M$42.90M$51.66M$25.81M$100.96MN/A$31.32MN/A
2025-06-30$162.33M$24.32M$58.60M$31.57M$106.38MN/A$32.31MN/A
2025-03-31$86.43M$69.78M$51.06M$29.51M$77.28MN/AN/AN/A
2024-12-31$79.55M$38.81M$43.22M$26.92M$86.54MN/A$3.07MN/A
2024-09-30$126.12M$25.39M$24.41M$18.55M$88.04MN/AN/AN/A
2024-06-30$421.08M$22.23M$28.57M$14.60M$64.07MN/A$2.13MN/A
2024-03-31$696.08M$16.76M$29.57M$11.46M$45.59MN/A$2.33MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-20 View
2025-09-30 10-Q 2025-11-05 View
2025-06-30 10-Q 2025-08-06 View
2025-03-31 10-Q 2025-05-07 View
2024-12-31 10-K 2025-02-14 View
2024-09-30 10-Q 2024-11-05 View
2024-06-30 10-Q 2024-08-07 View
2024-03-31 10-Q 2024-05-08 View

Community Notes

Loading notes...

Questions

Loading questions...